Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatectomy | 2 | 2020 | 1786 | 0.690 |
Why?
|
| Prostatic Hyperplasia | 1 | 2020 | 514 | 0.520 |
Why?
|
| Prostate | 2 | 2021 | 1757 | 0.490 |
Why?
|
| Lithotripsy | 1 | 2011 | 137 | 0.340 |
Why?
|
| Radiotherapy | 1 | 2016 | 1497 | 0.320 |
Why?
|
| Nephrectomy | 1 | 2014 | 928 | 0.320 |
Why?
|
| Androgen Antagonists | 1 | 2016 | 1411 | 0.280 |
Why?
|
| Ultrasonography | 1 | 2020 | 5992 | 0.270 |
Why?
|
| Laparoscopy | 1 | 2014 | 2039 | 0.200 |
Why?
|
| Penile Implantation | 1 | 2019 | 11 | 0.160 |
Why?
|
| Penile Prosthesis | 1 | 2019 | 32 | 0.160 |
Why?
|
| Silicones | 1 | 2020 | 228 | 0.160 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 3186 | 0.160 |
Why?
|
| Suction | 1 | 2019 | 268 | 0.150 |
Why?
|
| Prostatic Neoplasms | 2 | 2021 | 11094 | 0.150 |
Why?
|
| Urologic Surgical Procedures | 1 | 2020 | 281 | 0.140 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 4282 | 0.140 |
Why?
|
| Patient Selection | 2 | 2020 | 4252 | 0.130 |
Why?
|
| Organ Size | 1 | 2020 | 2261 | 0.120 |
Why?
|
| Comparative Effectiveness Research | 1 | 2020 | 713 | 0.120 |
Why?
|
| Veterans Health | 1 | 2016 | 216 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 2 | 2021 | 2463 | 0.110 |
Why?
|
| Hypertension | 1 | 2011 | 8616 | 0.090 |
Why?
|
| Learning | 1 | 2020 | 1754 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 2418 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 20144 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2020 | 4858 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2016 | 10100 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 13050 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11218 | 0.050 |
Why?
|
| Middle Aged | 5 | 2021 | 223257 | 0.040 |
Why?
|
| Male | 6 | 2021 | 364142 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5943 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1996 | 1802 | 0.040 |
Why?
|
| Scrotum | 1 | 2019 | 117 | 0.040 |
Why?
|
| HLA-A2 Antigen | 1 | 1996 | 207 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 222 | 0.030 |
Why?
|
| Humans | 9 | 2024 | 766766 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 2010 | 0.030 |
Why?
|
| Prevalence | 1 | 2011 | 15835 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 3212 | 0.020 |
Why?
|
| Parents | 1 | 2024 | 3593 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39309 | 0.020 |
Why?
|
| HIV-1 | 2 | 1996 | 6948 | 0.020 |
Why?
|
| United States | 1 | 2016 | 72951 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 171343 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 9244 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2020 | 6259 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2011 | 54871 | 0.020 |
Why?
|
| Logistic Models | 1 | 2019 | 13278 | 0.010 |
Why?
|
| Female | 2 | 2014 | 396520 | 0.010 |
Why?
|
| DNA Primers | 2 | 1996 | 2826 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 81635 | 0.010 |
Why?
|
| Time Factors | 2 | 2019 | 40149 | 0.010 |
Why?
|
| HIV Infections | 2 | 1996 | 17536 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2019 | 15831 | 0.010 |
Why?
|
| Zalcitabine | 1 | 1996 | 43 | 0.010 |
Why?
|
| Didanosine | 1 | 1996 | 151 | 0.010 |
Why?
|
| HIV Antigens | 1 | 1996 | 328 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 1996 | 301 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 1996 | 214 | 0.010 |
Why?
|
| Base Sequence | 2 | 1996 | 12415 | 0.010 |
Why?
|
| Lamivudine | 1 | 1996 | 367 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1996 | 13411 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 36567 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1996 | 826 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59550 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 17608 | 0.010 |
Why?
|
| Viremia | 1 | 1996 | 727 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1996 | 832 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1996 | 1159 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 1352 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59939 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65273 | 0.010 |
Why?
|
| Deoxycytidine | 1 | 1996 | 886 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1996 | 1195 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1996 | 2586 | 0.010 |
Why?
|
| Epitopes | 1 | 1996 | 2526 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 1996 | 1377 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1996 | 2201 | 0.000 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1996 | 1852 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6066 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 5503 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 223307 | 0.000 |
Why?
|
| Antiviral Agents | 1 | 1996 | 3070 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1996 | 6612 | 0.000 |
Why?
|
Concepts
(86)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_